Wednesday, August 30, 2017

Defense Verdict in 3rd Xarelto Bellwether Trial

This month, a jury in the third bellwether trial over the blood thinner Xarelto has sided with defendants Janssen Pharmaceuticals Inc. and Bayer. The jury deliberated for approximately three hours. Unlike the first two bellwether trials that took place in New Orleans, this one took place in Jackson, Mississippi. 

More than 18,000 cases have been filed in the MDL in New Orleans. Many more have been filed throughout the country in other state-consolidated actions. All lawsuits allege that Xarelto, an anticoagulant used to treat blood clots, caused plaintiffs to suffer from uncontrollable bleeding resulting in injury or death.

Pittman, Dutton & Hellums, P.C., is currently investigating Xarelto cases. If you or a loved one were prescribed Xarelto and suffered an irreversible internal bleeding that lead to hospitalization and/or death, contact Booth Samuels at toll free 1-866-515-8880 or by email at booths@pittmanudutton.com